Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 978 across all filing types
Latest filing 2019-11-15 Interim / Quarterly Rep…
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : quarterly financial information as of September 30, 2019
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report for Virbac, detailing consolidated revenue, performance by segment, net debt, and future outlook for the third quarter of 2019. It contains substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). It is not merely an announcement (RPA) or a simple earnings release (ER) as it provides detailed narrative and tabular financial breakdowns. 9M 2019
2019-11-15 English
Virbac : mise à disposition de l'information financière trimestrielle au 30 septembre 2019
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report for Virbac, titled 'information financière trimestrielle au 30 septembre 2019'. It provides detailed financial data, including consolidated revenue figures, segment analysis (companion animals vs. production animals), and debt levels. It is not a mere announcement of a report (RPA) because it contains substantive financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full fiscal year and provides actual financial statements/data. 9M 2019
2019-11-15 French
Virbac : Declaration of the number of shares and voting rights Oct 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and references Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the 'Total number of shares' and the 'Total number of voting rights' as of a specific date (October 31, 2019). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2019-11-06 English
Virbac : Déclaration d'actions et droits de vote 31/10/2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights) and explicitly references Article 223-16 of the AMF General Regulation. It presents a table detailing the total number of shares and the total gross and net voting rights as of a specific date (October 31, 2019). This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related voting rights disclosures.
2019-11-06 French
Virbac : solid +8.4% growth in revenue at constant exchange rates at the end of September, 2019
Earnings Release Classification · 96% confidence The document provides a detailed breakdown of quarterly and year-to-date revenue, growth metrics, and financial outlook for Virbac. While it contains an 'Attachment' link at the bottom, the document itself contains the full text of the earnings release, including detailed analysis of performance by region and species, which exceeds the scope of a simple announcement. Therefore, it is classified as an Earnings Release (ER). 9M 2019
2019-10-11 English
Virbac : solide croissance de +8,4% du chiffre d’affaires à taux constants à fin septembre 2019
Earnings Release Classification · 98% confidence The document is a press release dated October 11, 2019, detailing key financial figures for the first nine months (Neuf mois 2019) and the third quarter (trimestriel) of 2019. It explicitly states 'Chiffre d’affaires' (Revenue) figures and provides commentary on performance by region and species. This structure—a concise announcement of period-end financial results with key highlights—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), as it focuses on highlights and outlook adjustments rather than full statutory financial statements. The presence of a link to an attachment suggests it might also relate to an RPA, but the core content is the earnings summary itself. 9M 2019
2019-10-11 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.